The largest database of trusted experimental protocols

Genomiphi v2 dna amplification kit

Manufactured by GE Healthcare
Sourced in United Kingdom, United States, Sweden

The GenomiPhi V2 DNA Amplification Kit is a laboratory equipment product designed for the random amplification of genomic DNA. It is a commonly used tool in various molecular biology applications, including whole-genome amplification and DNA sample preparation.

Automatically generated - may contain errors

41 protocols using genomiphi v2 dna amplification kit

1

Metagenomic DNA Amplification from Amerindian and Puerto Rican Samples

Check if the same lab product or an alternative is used in the 5 most similar protocols
We performed MDA on fecal and oral metagenomic DNA from Amerindian subjects 3, 5, 6, and 23 and the five Puerto Rican subjects with the illustra GenomiPhi V2 DNA Amplification Kit (GE Healthcare Life Sciences). The recommended protocol was followed with a 2-hour incubation. We pooled three to six reactions per sample to reduce MDA template amplification bias.
+ Open protocol
+ Expand
2

Whole Genome Amplification of Tissue Punches

Check if the same lab product or an alternative is used in the 5 most similar protocols
We performed WGA on each punch using the illustra GenomiPhi V2 DNA Amplification kit (GE Healthcare Life Sciences). Punches were transferred in 0.2 mL sterile tubes using a sterile tip. We performed reactions following the manufacturer’s instructions, immersing each punch in 9 μL of sample buffer and keeping tubes on ice at all times after the denaturation step. After amplification, we quantified DNA using the Qubit dsDNA BR assay (Invitrogen, USA).
+ Open protocol
+ Expand
3

Metagenomic Sequencing of Hot Spring Soil

Check if the same lab product or an alternative is used in the 5 most similar protocols
The soil sample was collected by scratching the surface of a spout of a hot spring (70 °C and pH 7.2 when sampled) by a spatula in the Onikobe-onsen-kyo geothermal area at lat. 38˚48’ and at long. 140˚40’ (Miyagi, Japan) in June, 2009. Metagenomic DNA was extracted from microbes in 10 g of the soil using an ISOIL Large for Beads, ver. 2, DNA extraction kit (Nippon Gene, Tokyo, Japan). Five micrograms of the extracted DNA were sequenced using a GS FLX Titanium DNA sequencer (Roche Diagnostics, Basel, Switzerland) according to the supplier’s protocol. In addition, the genomic DNA was amplified using a GenomiPhi V2 DNA amplification kit (GE Healthcare, Little Chalfont, UK) and then sequenced using a Hiseq 2000 DNA sequencer (Illumina, San Diego, CA, USA) according to the supplier’s protocol. Sequences with a total length of 1.11 Gbp and average length of 396 bp for each read were obtained from the former sequence, and sequences with a total length of 83.1 Gbp and average length of 92.7 bp for each read were obtained from the latter sequence. Uncertain sequences were trimmed from the raw sequences based on the quality score defined, and the resulting sequences were used for de novo assembly using CLC Genomics Workbench software, ver. 4.0.
+ Open protocol
+ Expand
4

Metagenomic DNA Amplification from Amerindian and Puerto Rican Samples

Check if the same lab product or an alternative is used in the 5 most similar protocols
We performed MDA on fecal and oral metagenomic DNA from Amerindian subjects 3, 5, 6, and 23 and the five Puerto Rican subjects with the illustra GenomiPhi V2 DNA Amplification Kit (GE Healthcare Life Sciences). The recommended protocol was followed with a 2-hour incubation. We pooled three to six reactions per sample to reduce MDA template amplification bias.
+ Open protocol
+ Expand
5

Genetic Screening of PROCR Locus in Ghanaians

Check if the same lab product or an alternative is used in the 5 most similar protocols
In order to screen the PROCR locus on chromosome 20 (chr20: 33,758,824–33,765,355) for genetic variants, DNA from 3,771 unrelated Ghanaian individuals (1,905 SM cases and 1,866 healthy controls) was used for HRM. Prior to the screen, genomic DNA had been whole-genome amplified by Genomiphi V2 DNA amplification kit (GE Healthcare). DNA samples were then amplified by PCR using primers that captured 1,100 bp upstream of the transcription start site, exons and their flanking regions, and 750 bp of the 3′-UTR. Oligonucleotides were designed using LightCycler Probe Design Software 2.0 (Roche Applied Science) against reference transcript NCBI NM_006404. Sequences of oligonucleotides and PCR conditions for HRM assays are listed in S1 Table. Previously unknown SNPs and singletons were confirmed by re-sequencing genomic DNA. In addition, 13 variants detected by HRM were genotyped by allele-specific hybridization in a Roche LightCycler device (S2 Table).
+ Open protocol
+ Expand
6

Genomic DNA Extraction and SNP Genotyping

Check if the same lab product or an alternative is used in the 5 most similar protocols
gDNA was extracted using the wizard SV 96 genomic DNA purification system (Promega, Leiden, The Netherlands). In case of a low yield, pre-amplification of gDNA was performed with the GenomiPhi V2 DNA Amplification Kit (GE Healthcare, Diegem, Belgium). 10 ng of gDNA was used in Taqman SNP genotyping assays (Applied Biosystems, Life Technologies, Merelbeke, Belgium) for SNPs rs301, rs328 and rs13702 on an ABI Prism 7300 Real Time PCR System (Applied Biosystems, Life Technologies).
+ Open protocol
+ Expand
7

DNA Extraction and Amplification Methods

Check if the same lab product or an alternative is used in the 5 most similar protocols
For cohort 1, DNA was extracted using DNeasy Blood and Tissue kit (Qiagen) as previously described (O'Brien et al., 2014 (link)). For cohort 2, DNAs were extracted using QIAamp DNA mini kit (QIAgen) according to standard protocols. For the third cohort, DNA extraction was performed from specimens preserved in RNAlater, using Trizol reagent (Invitrogen life technologie) with NucleoSpin Tissue (Macherey-Nagel).
DNA quantity and quality were checked for all samples using a Nanodrop ND-1000 spectrophotometer (NanoDrop Technologies, USA). Of the total of 509 DNA samples, 39 with DNA concentrations less than 20 ng/μl were removed. DNA samples were pre-amplified using the GenomiPhi V2 DNA Amplification kit (GE Healthcare) according to the manufacturer's instructions. Briefly, 25 ng of each DNA sample was heat-denatured at 95°C. After addition of the enzyme solution, the sample was incubated at 30°C for 90 min. DNA polymerases were then heat-inactivated at 65°C for 10 min and samples were stored at −20°C until use.
+ Open protocol
+ Expand
8

Blood Collection and DNA Extraction for Rectal Cancer

Check if the same lab product or an alternative is used in the 5 most similar protocols
Blood was collected in EDTA-vacutainers (BD, Franklin Lakes, NJ) from patients with rectal cancer who underwent pre-neoadjuvant chemoradiation and stored at 4°C until further use. Genomic DNA was extracted from whole blood samples from using Qiagen® DNeasy Tissue Extraction Kit (Valencia, CA). Whole genome amplification of each sample was performed using the illustra GenomiPhi V2 DNA Amplification Kit (GE Healthcare, Pittsburgh, PA). DNA concentration was determined after whole genome amplification using spectrophotometry.
+ Open protocol
+ Expand
9

DNA Sample Preparation and Whole Genome Amplification

Check if the same lab product or an alternative is used in the 5 most similar protocols
The 104 DNA samples from our lab collection were obtained from peripheral blood, saliva or cultured cells. Target sequencing required specific quality and quantity parameters for the DNA to be analysed: 1) absence or low amount of DNA degradation; 2) quantity ≥ 3 μg; 3) concentration ≥ 37.5 ng/μl; 4) purity, A260/280 = 1.8–2.0. Concentration and purity were measured using a NanoDrop 1000 spectrophotometer, produced by Thermo Fisher Scientific. Degradation was assessed by means of an electrophoretic run on a 1 % agarose gel. We performed a whole genome amplification (WGA) of 59 samples with an insufficient quantity of DNA, using the GenomiPhi V2 DNA Amplification kit (GE Healthcare) according to the manufacturer’s protocol.
+ Open protocol
+ Expand
10

High-Resolution HLA Genotyping in Asia

Check if the same lab product or an alternative is used in the 5 most similar protocols
High resolution (4-digit) genotyping of HLA-DPA1 and -DPB1 alleles was performed for HBV patients, resolved individuals, and healthy controls in Japan, Korea, Hong Kong, and Thailand. LABType SSO HLA DPA1/DPB1 kit (One Lambda, CA) and a Luminex Multi-Analyte Profiling system (xMAP; Luminex, Austin, TX) were used for genotyping, in according with the manufacturer's protocol. Because of the small quantity of genomic DNA in some Korean samples, we performed whole genome amplification for a total of 486 samples using GenomiPhi v2 DNA Amplification kit (GE Healthcare Life Sciences, UK), in accordance with the manufacturer's instruction.
A total of 2,895 samples were successfully genotyped and characteristics of these samples are summarized in Table S1.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!